Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function

Sichuan University

Status and phase: Unknown; Phase 4

Conditions: Coronary Heart Disease; Essential Hypertension

Treatments: Drug: danshen dripping pill

Study type: Interventional

Funder types: Other

Identifiers

NCT01825759

West China Hospital

Details and patient eligibility

About

The Impact of Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension

Full description

Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension.We can accorand the pwv ,IMT and MDA to assess the impact of heart and artery structure and function.

Enrollment: 200 estimated patients

Sex: All

Ages: 35 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:coronary heart disease，primary hypertension， -

Exclusion Criteria:secondary hypertension，diabetes mellitus，chronic renal disease，cardiac insufficiency

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

200 participants in 1 patient group

danshen dripping pill

Experimental group

Description:

danshen dripping pill 27mg ten pills by mouth every 8 hours for one year

Treatment:

Drug: danshen dripping pill